Imaging Bioresorbable Vascular Scaffolds – at the Border between Science and Technology

1. Foussas SG, Tsiaousis GZ. Revascularization treatment in patients with coronary artery disease. Hippokratia. 2008;12:3-10.Search in Google Scholar

2. Windecker S, Stortecky S, Stefanini GG, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348:g3859.10.1136/bmj.g3859Search in Google Scholar

3. Grube E, Chevalier B, Smits P, et al. The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. JACC Cardiovascular Interventions. 2011;4:168-175.10.1016/j.jcin.2010.11.006Search in Google Scholar

4. Palmerini T, Benedetto U, Biondi-Zoccai G, et al. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2015;65:2496-2507.10.1016/j.jacc.2015.04.017Search in Google Scholar

5. Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125:2873-2891.10.1161/CIRCULATIONAHA.112.097014Search in Google Scholar

6. Kereiakes DJ, Serryus PW, Stone GW. Bioresorbable Vascular Scaffolds for Coronary Revascularization. Circulation. 2016;134:168-182.10.1161/CIRCULATIONAHA.116.021539Search in Google Scholar

7. Yang X, Ahmed M, Cutlip DE. When To Use Bioresorbable Vascular Scaffolds. US Cardiology Review. 2017;11:25-30.10.15420/usc.2017:3:2Search in Google Scholar

8. Bil J, Gil RJ. Bioresorbable vascular scaffolds—what does the future bring? Thorac Dis. 2016;8:E741-E745.10.21037/jtd.2016.05.80499976027619478Search in Google Scholar

9. Brugaletta S, Heo JH, Garcia-Garcia HM, et al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J. 2012;33:1325-1333.Search in Google Scholar

10. Ormiston JA, Serruys PW, Onuma Y, et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimuseluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv. 2012;5:620-632.10.1161/CIRCINTERVENTIONS.112.97154923048057Search in Google Scholar

11. Serruys PW, Ormiston J, van Geuns RJ, et al. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up. J Am Coll Cardiol. 2016;67:766-776.10.1016/j.jacc.2015.11.06026892411Search in Google Scholar

12. Onuma Y, Serruys PW, Perkins LE, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010;122:2288-2300.10.1161/CIRCULATIONAHA.109.92152820975003Search in Google Scholar

13. Serruys PW, Onuma Y, Garcia-Garcia HM, et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention. 2014;9:1271-1284.10.4244/EIJV9I11A21724291783Search in Google Scholar

14. Simsek C, Karanasos A, Magro M, et al. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. EuroIntervention. 2016;11:996-1003.Search in Google Scholar

15. Collet C, Chevalier B, Cequier A, et al. Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds. JACC Cardiovasc Imaging. 2018;11:722-732.10.1016/j.jcmg.2017.04.01328734923Search in Google Scholar

16. Ferenț I, Mester A, Chițu M, et al. CTA Assessment of Coronary Atherosclerotic Plaque Evolution after BVS Implantation – a Follow-up Study. Journal of Interdisciplinary Medicine. 2018 Sep 23; [Epub ahead of print]10.2478/jim-2018-0035Search in Google Scholar

17. Ferenț I, Mester A, Chițu M, et al. CTA Evaluation of Bioresorbable Scaffolds versus Metallic Coronary Stents – a Feasibility Study. Journal of Interdisciplinary Medicine. 2018 Sep 23; [Epub ahead of print]10.2478/jim-2018-0033Search in Google Scholar